Caris Net Receivables from 2010 to 2026

CAI Stock  USD 25.00  0.55  2.15%   
Caris Life's Net Receivables is increasing with stable movements from year to year. Net Receivables is predicted to flatten to about 79.8 M. For the period between 2010 and 2026, Caris Life, Net Receivables quarterly trend regression had mean deviation of  31,291,119 and range of 144.5 M. View All Fundamentals
 
Net Receivables  
First Reported
2006-12-31
Previous Quarter
50.9 M
Current Value
26.7 M
Quarterly Volatility
47.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Caris Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caris Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 61.8 M, Interest Expense of 33.1 M or Total Revenue of 497.8 M, as well as many indicators such as Price To Sales Ratio of 16.34, Dividend Yield of 0.0333 or Days Sales Outstanding of 175. Caris financial statements analysis is a perfect complement when working with Caris Life Valuation or Volatility modules.
  
Build AI portfolio with Caris Stock
Check out the analysis of Caris Life Correlation against competitors.

Latest Caris Life's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Caris Life Sciences over the last few years. It is Caris Life's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caris Life's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Pretty Stable
   Net Receivables   
       Timeline  

Caris Net Receivables Regression Statistics

Arithmetic Mean83,430,585
Geometric Mean74,208,594
Coefficient Of Variation50.14
Mean Deviation31,291,119
Median76,442,000
Standard Deviation41,831,291
Sample Variance1749.9T
Range144.5M
R-Value0.25
Mean Square Error1749.5T
R-Squared0.06
Significance0.33
Slope2,074,076
Total Sum of Squares27997.7T

Caris Net Receivables History

202679.8 M
2025101.5 M
202488.2 M
202355.3 M
202140.2 M
2020144.3 M
2019159.7 M

About Caris Life Financial Statements

Investors use fundamental indicators, such as Caris Life's Net Receivables, to determine how well the company is positioned to perform in the future. Although Caris Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Receivables101.5 M79.8 M

Currently Active Assets on Macroaxis

When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:
Check out the analysis of Caris Life Correlation against competitors.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Trading Companies & Distributors space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caris Life. If investors know Caris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.25)
Revenue Per Share
3.18
Quarterly Revenue Growth
0.499
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caris Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caris Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caris Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.